| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 1 | 0 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 0 | 0 | 1 |
| Alanine racemase, biosynthetic | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 1 | 4 |
| Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 2 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
| AR protein | 4 | 0 | 0 | 4 |
| retinoic acid nuclear receptor alpha variant 1 | 3 | 0 | 0 | 3 |
| estrogen nuclear receptor alpha | 4 | 0 | 0 | 4 |
| thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform 2 | 1 | 0 | 0 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
| Heat shock protein HSP 90-alpha | 0 | 0 | 1 | 1 |
| Botulinum neurotoxin type A | 0 | 1 | 0 | 1 |
| Neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor 2 | 2 | 0 | 0 | 2 |
| Nitric oxide synthase, endothelial | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 0 | 1 | 1 |
| Phosphatidylinositol 4-kinase alpha | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase | 0 | 0 | 1 | 1 |
| Phosphatidylinositol 4-kinase type 2-beta | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-kinase type 2-alpha | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-kinase beta | 0 | 1 | 0 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
| progesterone receptor | 2 | 0 | 0 | 2 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 3 | 0 | 0 | 3 |
| glucocorticoid receptor [Homo sapiens] | 2 | 0 | 0 | 2 |
| retinoid X nuclear receptor alpha | 1 | 0 | 0 | 1 |
| estrogen-related nuclear receptor alpha | 2 | 0 | 0 | 2 |
| pregnane X nuclear receptor | 2 | 0 | 0 | 2 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 1 | 0 | 0 | 1 |
| aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
| nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 1 | 0 | 0 | 1 |
| Interferon beta | 3 | 0 | 0 | 3 |
| ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
| Ataxin-2 | 2 | 0 | 0 | 2 |
| Sphingosine 1-phosphate receptor 1 | 0 | 0 | 1 | 1 |
| RCG53912, isoform CRA_a | 0 | 0 | 0 | 1 |
| Sphingosine kinase 1 | 0 | 0 | 0 | 1 |
| Sphingosine kinase 2 | 0 | 0 | 0 | 1 |
| Sphingosine kinase 1 | 0 | 0 | 0 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 3 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 3 |
| Serine racemase | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 3 |
| Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
| Chain A, ALPHA1,2-MANNOSIDASE | 0 | 1 | 0 | 1 |
| Chain A, ALPHA1,2-MANNOSIDASE | 0 | 1 | 0 | 1 |
| Chain A, Alpha-mannosidase II | 0 | 1 | 0 | 1 |
| Chain A, PUTATIVE ALPHA-1,2-MANNOSIDASE | 0 | 1 | 0 | 1 |
| Chain A, Putative Alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Chain B, Alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Chain A, PUTATIVE ALPHA-1,2-MANNOSIDASE | 0 | 1 | 0 | 1 |
| Alpha-1,2-mannosidase family protein | 0 | 1 | 0 | 1 |
| Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Alpha-1,2-mannosidase, putative | 0 | 1 | 0 | 1 |
| Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Glycoside hydrolase family 92 | 0 | 1 | 0 | 1 |
| Glycoside hydrolase family 92 | 0 | 1 | 0 | 1 |
| Alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Alpha-1,2-mannosidase, putative | 0 | 1 | 0 | 1 |
| Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Alpha-1,2-mannosidase, putative | 0 | 1 | 0 | 1 |
| Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Putative alpha-1,2-mannosidase | 0 | 1 | 0 | 1 |
| Alpha-1,2-mannosidase family protein | 0 | 1 | 0 | 1 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
| G | 1 | 0 | 0 | 1 |
| polyprotein | 1 | 0 | 0 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
| Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 2 | 2 |
| Spike glycoprotein | 1 | 0 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
| cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
| Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
| geminin | 1 | 0 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
| lamin isoform A-delta10 | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 2 | 0 | 2 |
| Multidrug resistance-associated protein 4 | 0 | 2 | 0 | 2 |
| Bile salt export pump | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 2 | 0 | 2 |
| Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| RAR-related orphan receptor gamma | 1 | 0 | 0 | 1 |
| TDP1 protein | 1 | 0 | 0 | 1 |
| GLI family zinc finger 3 | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 2 | 0 | 2 |
| Glucocorticoid receptor | 0 | 2 | 1 | 8 |
| Cellular tumor antigen p53 | 1 | 0 | 0 | 1 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Androgen receptor | 0 | 1 | 0 | 1 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |